2. Anti-infection
  3. Bacterial
  4. Suvratoxumab

Suvratoxumab  (Synonyms: 苏托舒单抗; MEDI4893)

目录号: HY-P99583 纯度: 98.79%
COA

摩尔计算器

Suvratoxumab (MEDI4893) 是一种长效且具有亲和力高的 人源抗 α-毒素单克隆抗体 (IgG1κ 型)。Suvratoxumab 能有效中和 α-毒素 (一种关键的金黄色葡萄球菌毒力因子)。Suvratoxumab 可提高免疫功能低下的小鼠肺炎模型的存活率并减少肺损伤。Suvratoxumab 还可增强 Vancomycin (HY-B0671) 或 Linezolid (HY-10394) 的抗菌活性。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

CAS No. : 1629620-18-3

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥3000
In-stock
5 mg ￥7800
In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

Customer Review

Suvratoxumab 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Suvratoxumab (MEDI4893) is a long-acting, high-affinity human anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin (HY-B0671) or Linezolid (HY-10394)[1][2][3].

同型

Human IgG1 kappa
推荐同型对照抗体
种属

Human
IC50 & Target

α-toxin of S. aureus[1][2][3].
体内研究
(In Vivo)

Suvratoxumab (5, 15, 45 mg/kg; i.p.; single) 可提高免疫功能低下的小鼠肺炎模型的存活率[1]。
Suvratoxumab (15 mg/kg; i.p.; single) 可减少小鼠的肺损伤并增加巨噬细胞的吞噬作用[1]。
Suvratoxumab (15 mg/kg; i.p.; single) 可增强抗生素（万古霉素或利奈唑胺）处理小鼠的有效性[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Specific-pathogen-free, 7- to 9-week-old, female C57BL/6J mice (immunocompromised pneumonia model)[1].
Dosage: 5, 15, 45 mg/kg
Administration: Intraperitoneal injection; single
Result: Resulted in dose-dependent increases in survival rates and reductions in bacterial CFU.
Animal Model: Specific-pathogen-free, 7- to 9-week-old, female C57BL/6J mice (immunocompromised pneumonia model)[1].
Dosage: 15 mg/kg
Administration: Intraperitoneal injection; single
Result: Prophylaxis protected the lungs of S. aureus-infected immunocompromised mice from α toxin-mediated damage.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

苏托舒单抗
运输条件

Shipping with dry ice.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 kappa
纯度 & 产品资料
参考文献

Suvratoxumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Suvratoxumab1629620-18-3MEDI4893苏托舒单抗MEDI 4893MEDI-4893BacterialS. aureusbacterialimmunocompromisedpulmonary damageInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Suvratoxumab
目录号：
HY-P99583
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z